Group One Trading’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-292
| Closed | -$817 | – | 7864 |
|
|
2025
Q1 | $1.28K | Sell |
292
-27,974
| -99% | -$126K | ﹤0.01% | 7120 |
|
|
2024
Q4 | $132K | Buy |
28,266
+3,800
| +16% | +$25.6K | ﹤0.01% | 4282 |
|
|
2024
Q3 | $172K | Buy |
24,466
+24,447
| +128,668% | +$178K | ﹤0.01% | 3767 |
|
|
2024
Q2 | $130 | Sell |
19
-9,231
| -100% | -$85.8K | ﹤0.01% | 6542 |
|
|
2024
Q1 | $131K | Buy |
9,250
+7,619
| +467% | +$116K | ﹤0.01% | 3907 |
|
|
2023
Q4 | $12.3K | Buy |
+1,631
| New | +$14.9K | ﹤0.01% | 6078 |
|
|
2023
Q3 | – | Sell |
-2,157
| Closed | -$38.7K | – | 7568 |
|
|
2023
Q2 | $34.3K | Hold |
2,157
| – | – | ﹤0.01% | 5576 |
|
|
2023
Q1 | $15.5K | Buy |
+2,157
| New | +$15.3K | ﹤0.01% | 5685 |
|
|
2020
Q2 | – | Sell |
-1,340
| Closed | -$237K | – | 5727 |
|
|
2020
Q1 | $131K | Sell |
1,340
-8,497
| -86% | -$991K | ﹤0.01% | 3081 |
|
|
2019
Q4 | $1.13M | Buy |
9,837
+2,424
| +33% | +$214K | 0.01% | 1775 |
|
|
2019
Q3 | $404K | Buy |
7,413
+5,074
| +217% | +$572K | ﹤0.01% | 2511 |
|
|
2019
Q2 | $278K | Buy |
+2,339
| New | +$194K | ﹤0.01% | 2610 |
|
|
2019
Q1 | – | Sell |
-63
| Closed | -$2.55K | – | 4730 |
|
|
2018
Q4 | $2K | Buy |
+63
| New | +$2.56K | ﹤0.01% | 4637 |
|
|
2018
Q2 | – | Sell |
-1,801
| Closed | -$108K | – | 5033 |
|
|
2018
Q1 | $104K | Buy |
1,801
+423
| +31% | +$26.3K | ﹤0.01% | 3217 |
|
|
2017
Q4 | $48K | Buy |
1,378
+790
| +134% | +$26K | ﹤0.01% | 3748 |
|
|
2017
Q3 | $21K | Sell |
588
-102
| -15% | -$2.83K | ﹤0.01% | 4040 |
|
|
2017
Q2 | $17K | Hold |
690
| – | – | ﹤0.01% | 4005 |
|
|
2017
Q1 | $19K | Buy |
690
+160
| +30% | +$4.55K | ﹤0.01% | 3888 |
|
|
2016
Q4 | $15K | Buy |
530
+310
| +141% | +$10.1K | ﹤0.01% | 3805 |
|
|
2016
Q3 | $9K | Sell |
220
-1,179
| -84% | -$44.7K | ﹤0.01% | 4065 |
|
|
2016
Q2 | $44K | Buy |
1,399
+1,037
| +286% | +$46.9K | ﹤0.01% | 3378 |
|
|
2016
Q1 | $19K | Buy |
+362
| New | +$20.2K | ﹤0.01% | 3767 |
|
|
2015
Q4 | – | Sell |
-13,517
| Closed | -$1.19M | – | 4694 |
|
|
2015
Q3 | $1.11M | Sell |
13,517
-913
| -6% | -$117K | 0.02% | 1166 |
|
|
2015
Q2 | $2.34M | Buy |
14,430
+11,189
| +345% | +$3.78M | 0.03% | 651 |
|
|
2015
Q1 | $1.31M | Buy |
+3,241
| New | +$1.37M | 0.02% | 873 |
|
Group One Trading's ADVM Position: Q2 2025 in Review
Group One Trading sold out of Adverum Biotechnologies (ADVM) in Q2 2025, closing a stake of 292 shares — an estimated $817 sold.
Group One Trading first reported a position in ADVM in Q1 2015 and held it in 25 quarters. The position peaked at $2.34M in Q2 2015. 58 funds tracked by Wall St. Rank hold ADVM as of Q2 2025.
- Group One Trading reported no remaining Adverum Biotechnologies position as of Q2 2025 after selling out during the quarter.
- Group One Trading sold 292 Adverum Biotechnologies shares in Q2 2025, an estimated $817.
- Group One Trading first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 25 quarters.
- Group One Trading's Adverum Biotechnologies position peaked at $2.34M in Q2 2015.
- 58 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2025.
Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.